Investigational Treatment for Food Allergies

Trial Objective

Investigational Treatment for Food AllergiesOur researchers are trying to determine if a study medication called omalizumab alone or combined with oral immunotherapy may help people with multiple food allergies. Participants must have a peanut allergy and at least two other food allergies to milk, egg, wheat, cashew, hazelnut, or walnut.

Enrollment

This trial is active and currently recruiting.

Who Can Participate

Anyone between the ages of 2-55 years who has a peanut allergy and at least two other food allergies to milk, egg, wheat, cashew, hazelnut or walnut.

Age: 2-55    Gender: Any Gender


Estimated Time Commitment

This is a multi-stage study, with an individual study participation of up to 4 years and 8 months, but not past December 2023.



Compensation

Provided

Trial Contact

For more information, contact:

Caroline Bronchick

Caroline Bronchick
303.398.1409

Request More Information

Trial Location

National Jewish Main Campus, Denver, CO

Trial Sponsors

National Institute of Allergy and Infectious Diseases (NIAID)

Co-Investigators